BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7678716)

  • 1. Changes in expression of differentiation markers between normal ovarian cells and derived tumors.
    Van Niekerk CC; Ramaekers FC; Hanselaar AG; Aldeweireldt J; Poels LG
    Am J Pathol; 1993 Jan; 142(1):157-77. PubMed ID: 7678716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.
    van Niekerk CC; Boerman OC; Ramaekers FC; Poels LG
    Am J Pathol; 1991 Feb; 138(2):455-63. PubMed ID: 1992770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
    van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
    Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody against human ovarian tumor-associated antigens.
    Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
    J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
    Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
    Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
    Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K
    Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
    Gaggero G; Sola S; Mora M; Fulcheri E
    Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
    Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
    Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls.
    Ohishi Y; Kaku T; Oya M; Kobayashi H; Wake N; Tsuneyoshi M
    Gynecol Oncol; 2007 Oct; 107(1):30-8. PubMed ID: 17583777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of cytokeratin and vimentin filaments in mesothelial, granulosa and rete ovarii cells of the human ovary.
    Czernobilsky B; Moll R; Levy R; Franke WW
    Eur J Cell Biol; 1985 May; 37():175-90. PubMed ID: 3896804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
    Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
    Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.